Back to search
FDAFDA · Food and drugs·Recall number Z-2166-2013

Outlook Safety Infusion System Burette Set. For intravenous fluid administration.

Published September 18, 2013 · Recall initiated: August 5, 2013

Summary

FDA records medical device Class II recall Z-2166-2013, published September 18, 2013 and initiated August 5, 2013. Recalling firm: B. Braun Medical, Inc.; Status: Terminated; Reported quantity: 900; Lot: Catelog Number 375038, Lot Number 0061317318, Expiration Date: 04/30/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Reports were received of an incorrectly assembled Outlook Safety Infusion System Burette Set (Product Code 375038), and the investigation determined that one of the ULTRASITE injection sites and corresponding low pressure backcheck valve was assembled upside down.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
B. Braun Medical, Inc.
Distributor
Distributed in the states of FL, NY, NJ, and TX.
Lot
Catelog Number 375038, Lot Number 0061317318, Expiration Date: 04/30/2016
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Outlook Safety Infusion System Burette Set. For intravenous fluid administration. recalled?

Yes. FDA published recall Z-2166-2013 on September 18, 2013. Reported hazard: Reports were received of an incorrectly assembled Outlook Safety Infusion System Burette Set (Product Code 375038), and the investigation determined that one of the ULTRASITE injection sites and corresponding low pressure backcheck valve was assembled upside down.

What should I do if I have this product?

Voluntary: Firm initiated · Letter